Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease

Journal of Leukocyte Biology

Volumn 77, Issue 4, 2005, Pages 460-465

  Wehkamp, Jan ^a   Schmid, Michael ^b   Fellermann, Klaus ^b   Stange, Eduard F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Crohn's disease; E. coli Nissle 1917; NOD2; Paneth cells; Probiotic bacteria

Indexed keywords

BETA DEFENSIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; DEFENSIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT;

CHRONIC INFLAMMATION; COLON; COLON MUCOSA; CONFERENCE PAPER; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; ILEUM DISEASE; INTESTINE CELL; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE MUCOSA; PANETH CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; ULCERATIVE COLITIS;

CROHN DISEASE; DEFENSINS; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; INTESTINES; PHENOTYPE;

EID: 16844382886     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0904543     Document Type: Conference Paper

References (65)

1. Fellermann, K., Wehkamp, J., Herrlinger, K. R., Stange, E. F. (2003) Crohn's disease: a defensin deficiency syndrome? Eur. J. Gastroenterol. Hepatol. 15, 627-634.
2. Stallmach, A., Carstens, O. (2002) Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Inflamm. Bowel. Dis. 8, 213-218.
3. Hugot, J-P., Chamaillard, C., Zouali, H., Lesage, S., Cezard, J-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J-F., Sabbatou, M., Thomas, C. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
4. Hampe, J., Cuthbert, A., Croucher, P. J., Mirza, M. M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A. J., Bridger, S., van Deventer, S., Forbes, A., Nikolaus, S., Lennard-Jones, J. E., Foelsch, U. R., Krawezak, M., Lewis, C., Schreiber, S., Mathew, C. G. (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357, 1925-1928.
5. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karalluskas, R., Duerr, R. H., Achkar, J-P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G., Cho, J. H. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
6. Bonen, D. K., Cho, J. H. (2003) The genetics of inflammatory bowel disease. Gastroenterology 124, 521-536.
7. Girardin, S. E. (2003) NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872.
8. Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S., Nunez, G. (2001) NOD2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276, 4812-4818.
9. Ogura, Y., Lala, S., Xin, W., Smith, E., Dowds, T. A., Chen, F. F., Zimmermann, E., Tretiakova, M., Cho, J. H., Hart, J., Greenson, J. K., Keshav, S., Nunez, G. (2003) Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52, 1591-1597.
10. Lala, S., Ogura, Y., Osborne, C., Hor, S. Y., Bromfield, A., Davies, S., Ogunbiyi, O., Nunez, G., Keshav, S. (2003) Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125, 47-57.
11. Rosenstiel, P., Fantini, M., Brautigam, K., Kuhbacher, T., Waetzig, G. H., Seegert, D., Schreiber, S. (2003) TNF-α and IFN-α regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124, 1001-1009.
12. Hisamatsu, T., Suzuki, M., Reinecker, H. C., Nadeau, W. J., McCormick, B. A., Podolsky, D. K. (2003) CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124, 993-1000.
13. Cuthhert, A. P., Fisher, S. A., Mirza, M. M., King, K., Hampe, J., Croucher, P. J., Mascherelti, S., Sanderson, J., Forbes, A., Mansfield, J., Schreiber, S., Lewis, C. M., Mathew, C. C. (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122, 867-874.
14. Schmid, M., Fellermann, K., Wehkamp, J., Herrlinger, K., Stange, E. F. (2004) The role of defensins in the pathogenesis of chronic-inflammatory bowel disease. Z. Gastroenterol. 42, 333-338.
15. Huttner, K. M., Bevins, C. L. (1999) Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 45, 785-794.
16. Neut, C., Bulois, P., Desreumaux, P., Membre, J. M., Lederman, E., Gambiez, L., Cortot, A., Quandalle, P., van Kruiningen, H., Colombel, J. F. (2002) Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am. J. Gastroenterol. 97, 939-946.
17. Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., di Martino, P., Desreumaux, P., Gambiez, L., Joly, B., Cortot, A., Colombel, J-F. (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115, 1405-1413.
18. Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., Lochs, H. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44-54.
19. Linskens, R. K., Huijsdens, X. W., Savelkoul, P. H., Vandenbroucke- Grauls, C. M., Meuwissen, S. G. (2001) The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand. J. Gastroenterol. Suppl. 234, 29-40.
20. Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A. L., Barnich, N., Bringer, M. A., Swidsinski, A., Beaugerie, L., Colombel, J. F. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412-421.
21. Martin, H. M., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M., Singh, R., Englyst, H., Williams, H. F., Rhodes, J. M. (2004) Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127, 80-93.
22. Duchmann, R., May, E., Heike, M., Knolle, P., Neurath, M., Meyer zum Büschenfelde, K-H. (1999) T cell specifity and cross reactivity towards enterobacteria, Bacteroides. Bifidobacterium, and antigens from resident intestinal flora in humans. Gut 44, 812-818.
23. Harder, J., Bartels, J., Christophers, E., Schröder, J. M. (1997) A peptide antibiotic from human skin. Nature 387, 861.
24. Harder, J., Bartels, J., Christophers, E., Schröder, J. M. (2001) Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707-5713.
25. Zasloff, M. (1992) Antibiotic peptides as mediators of innate immunity. Curr. Opin. Immunol. 4, 3-7.
26. Jones, D. E., Bevins, C. L. (1992) Paneth cells of the human small intestine express an antimicrobial peptide gene. J. Biol. Chem. 267, 23216-23225.
27. Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720.
28. Zhao, C., Wang, I., Lehrer, R. I. (1996) Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396, 319-322.
29. Becker, M. N., Diamond, G., Verghese, M. W., Randell, S. H. (2000) CD14-dependent lipopolysaccharide-induced β-defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem. 275, 29731-29736.
30. Diamond, G., Russell, J. P., Bevins, C. L. (1996) Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc. Natl. Acad. Sci. USA 93, 5156-5160.
31. Wang, X., Zhang, Z., Louboutin, J. P., Moser, C., Weiner, D. J. Wilson, J. M. (2003) Airway epithelia regulate expression of human β-defensin 2 through Toll-like receptor 2. FASEB J. 17, 1727-1729.
32. Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. J., Kwak, L. W. (2002) Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298, 1025-1029.
33. Otte, J. M., Kierine, K., Herzig, K. H. (2003) Antimicrobial peptides in innate immunity of the human intestine. J. Gastroenterol. 38, 717-726.
34. Cario, E., Gerken, G., Podolsky, D. K. (2002) "For whom the bell tolls!"-innate defense mechanisms and survival strategies of the intestinal epithelium against lumenal pathogens. Z. Gastroenterol. 40, 983-990.
35. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karalluskas, R., Duerr, R. H., Achkar, J-P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G., Cho, J. H. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's diease. Nature 411, 603-606.
36. Wehkamp, J., Harder, J., Wehkamp, K., Wehkamp v.Meissner, B., Schlee, M., Enders, C., Sonnenborn, U., Nuding, S., Fellermann, K., Schroeder, J. M., Stange, E. F. (2004) NF-κB and AP-1 mediated induction of human β defensin-2 in intestinal epithelial cells by E. coli Nissle 1917: a novel effect of a probiotic bacterium. Infect. Immun. 72, 5750-5758.
37. Liu, L., Roberts, A. A., Ganz, T. (2003) By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J. Immunol. 170, 575-580.
38. Wehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K. R., Fellermann, K., Schroeder, J. M., Stange, E. F. (2003) Inducible and constitutive β-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm. Bowel. Dis. 9, 215-223.
39. Fahlgren, A., Hammarstrom, S., Danielsson, A., Hammarstrom, M. L. (2003) Increased expression of antimicrobial peptides and lysozyme in colonie epithelial cells of patients with ulcerative colitis. Clin. Exp. Immunol. 131, 90-101.
40. O'Neil, D. A., Porter, E. M., Elewaut, D., Anderson, G. M., Eckmann, L., Ganz, T., Kagnoff, M. F. (1999) Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163, 6718-6724.
41. Wehkamp, J., Fellermann, K., Herrlinger, K. R., Baxmann, S., Schmidt, K., Schwind, B., Duchrow, M., Wohlschlager, C., Feller, A. C., Stange, E. F. (2002) Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 14, 745-752.
42. Wehkamp, J., Schmidt, K., Herrlinger, K. R., Baxmann, S., Behling, S., Wohlschlager, C., Feller, A. C., Stange, E. F., Fellermann, K. (2003) Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J. Clin. Pathol. 56, 352-357.
43. Ayabe, T., Satchell, D. P., Wilson, C. L., Parks, W. C., Selsted, M. E., Ouellette, A. J. (2000) Secretion of microbicidal α-defensins by intestinal Paneth cell response to bacteria. Nat. Immunol. 8, 113-118.
44. Ghosh, D., Porter, E., Shen, B., Lee, S. K., Wilk, D., Drazba, J., Yadav, S. P., Crabb, J. W., Ganz, T., Bevins, C. L. (2002) Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3, 583-590.
45. Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y., Bevins, C. L. (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422, 522-526.
46. Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., Parks, W. C. (1999) Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113-117.
47. Rumio, C., Besusso, D., Palazzo, M., Selleri, S., Sfondrini, L., Dubini, F., Menard, S., Balsari, A. (2004) Degranulation of Paneth cells via Toll-like receptor 9. Am. J. Pathol. 165, 373-381.
48. Salzman, N. H., Chou, M. M., de Jong, H., Liu, L., Porter, E. M., Paterson, Y. (2003) Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect. Immun. 71, 1109-1115.
49. Cunliffe, R. N., Kamal, M., Rose, F. R., James, P. D., Mahida, Y. R. (2002) Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa. J. Clin. Pathol. 55, 298-304.
50. Cunliffe, R. N., Rose, F. R., Keyte, J., Abberley, L., Chan, W. C., Mahida, Y. R. (2001) Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some viloous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 48, 176-185.
51. Wehkamp, J., Schwind, B., Herrlinger, K. R., Baxmann, S., Schmidt, K., Duchrow, M., Wohlschlager, C., Feller, A. C., Stange, E. F., Fellermann, K. (2002) Innate immunity and colonic inflammation: enhanced expression of epithelial α-defensins. Dig. Dis. Sci. 47, 1349-1355.
52. Tollin, M., Bergman, P., Svenberg, T., Jornvall, H., Gudmundsson, G. H., Agerberth, B. (2003) Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24, 523-530.
53. Fahlgren, A., Hammarstrom, S., Danielsson, A., Hammarstrom, M. L. (2004) β-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin. Exp. Immunol. 137, 379-385.
54. Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schaeffeler, E., Schlee, M., Stallmach, A., Noack, F., Fritz, P., Schroder, J. M., Bevins, C. L., Fellermann, K., Stange, E. F. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 53, 1658-1664.
55. Sartor, R. B. (1997) Review article: role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment. Pharmacol. Ther. 11 (Suppl. 3), 17-22.
56. Schultz, M., Scholmerich, J., Rath, H. C. (2003) Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Dig. Dis. 21, 105-128.
57. Kruis, W., Schutz, E., Fric, P., Fixa, B., Judmaier, G., Stolte, M. (1997) Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 11, 853-858.
58. Rembacken, B. J., Snelling, A. M., Hawkey, P. M., Chalmers, D. M., Axon, A. T. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet 354, 635-639.
59. Kruis, W., Fric, P., Stolte, M. (2001) Maintenance of remission in ulcerative colitis is equally effective with Echerichia coli 1917 and with standard mesalamine. Gastroenterology 120, A127.
60. Lammers, K. M., Helwig, U., Swennen, E., Rizzello, F., Venturi, A., Caramelli, E., Kamm, M. A., Brigidi, P., Gionchetti, P., Campieri, M. (2002) Effect of probiotic strains on interleukin 8 production by HT29/ 19A cells. Am. J. Gastroenterol. 97, 1182-1186.
61. Otte, J. M., Podolsky, D. K. (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G613-G626.
62. Evans, J. D., Lopez, D. L. (2004) Bacterial probiotics induce an immune response in the honey bee (Hymenoptera: Apidae). J. Econ. Entomol. 97, 752-756.
63. Cario, E., Podolsky, D. K. (2000) Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010-7017.
64. Franchimont, D., Vermeire, S., El Housni, H., Pierik, M., Van Steen, K., Gustot, T., Quertinmont, E., Abramowicz, M., Van Gossum, A., Deviere, J., Rutgeerts, P. (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299 gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53, 987-992.
65. Torok, H. P., Glas, J., Tonenchi, L., Mussack, T., Folwaczny, C. (2004) Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin.Immunol. 112, 85-91.